APA (7th ed.) Citation

N, M., J, S., KJ, T., DA, W., KA, L., WA, R., . . . YG, S. (2020). MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells. Cell death & disease, 11(6), 443. https://doi.org/10.1038/s41419-020-2646-2

Chicago Style (17th ed.) Citation

N, Mukherjee, et al. "MCL1 Inhibitors S63845/MIK665 Plus Navitoclax Synergistically Kill Difficult-to-treat Melanoma Cells." Cell Death & Disease 11, no. 6 (2020): 443. https://doi.org/10.1038/s41419-020-2646-2.

MLA (9th ed.) Citation

N, Mukherjee, et al. "MCL1 Inhibitors S63845/MIK665 Plus Navitoclax Synergistically Kill Difficult-to-treat Melanoma Cells." Cell Death & Disease, vol. 11, no. 6, 2020, p. 443, https://doi.org/10.1038/s41419-020-2646-2.